JP Morgan Chase
FLNA

JP Morgan Chase’s Filana Therapeutics FLNA Stock Holding History

JP Morgan Chase’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,500
Closed -$183K – 7679
2024
Q4 		$183K Buy
+77,500
New +$1.36M ﹤0.01% 5513
2023
Q4 		– Sell
-200,000
Closed -$3.33M – 7833
2023
Q3 		$3.33M Buy
+200,000
New +$3.96M ﹤0.01% 3139
2021
Q1 		– Sell
-20,300
Closed -$138K – 6313
2020
Q4 		$138K Buy
20,300
+19,300
+1,930% +$172K ﹤0.01% 4918
2020
Q3 		$11K Buy
+1,000
New +$4.51K ﹤0.01% 5247

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase's FLNA Position: Q1 2026 in Review

JP Morgan Chase held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 13 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7406.

JP Morgan Chase first reported a position in FLNA in Q2 2013 and has held it in 31 quarters since. The position peaked at $2.21M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • JP Morgan Chase held 13 shares of Filana Therapeutics worth $21 as of Q1 2026.
  • JP Morgan Chase left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7406 holding.
  • JP Morgan Chase first reported a position in Filana Therapeutics in Q2 2013 and has held it in 31 quarters since.
  • JP Morgan Chase's Filana Therapeutics position peaked at $2.21M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.